Abstract:Objective To investigate the influence of long-term inhaled glucocorticoid combined with maximum load inspiratory muscle training on symptom relief and exercise endurance of stable chronic obstructive pulmonary disease (COPD).Methods From July 2019 to February 2022, 124 patients with stable COPD were selected, and they were divided into a study group (62 cases) and a control group (62 cases) by random number table method. The control group received long-term inhaled glucocorticoid therapy, and the study group was additionally given inspiratory muscle training with maximum load. Both two groups were treated for 6 months. Lung function, dyspnea, immune function, exercise endurance and quality of life were compared between the two groups.Results The differences of forced expiratory volume (FEV1), forced vital capacity (FVC) and FEV1/FVC in the first second before and after treatment in the study group were higher than those in the control group (P < 0.05). The difference of MRC dyspnea scale before and after treatment in the study group was higher than that in the control group (P < 0.05). The difference values of CD3+, CD4+, CD4+/CD8+ in the study group before and after treatment were higher than those in the control group (P < 0.05). The difference of 6-minute walking distance (6MWD) before and after treatment in the study group was higher than that in the control group (P < 0.05). The difference of COPD self-assessment test questionnaire (CAT) scores before and after treatment was higher in the study group than in the control group (P < 0.05).Conclusion Long-term inhaled corticosteroids combined with maximum load inspiratory muscle training can promote symptom relief, improve lung function, immune function, quality of life and exercise endurance in stable COPD patients.